These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 28413991)

  • 1. Potential Role of Endothelin in Early Vascular Aging.
    Trindade M; Oigman W; Fritsch Neves M
    Curr Hypertens Rev; 2017; 13(1):33-40. PubMed ID: 28413991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endothelin system in pulmonary arterial hypertension.
    Galié N; Manes A; Branzi A
    Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow.
    Black SM; Mata-Greenwood E; Dettman RW; Ovadia B; Fitzgerald RK; Reinhartz O; Thelitz S; Steinhorn RH; Gerrets R; Hendricks-Munoz K; Ross GA; Bekker JM; Johengen MJ; Fineman JR
    Circulation; 2003 Sep; 108(13):1646-54. PubMed ID: 12963646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired endothelin calcium signaling coupled to endothelin type B receptors in penile arteries from insulin-resistant obese Zucker rats.
    Contreras C; Sánchez A; Martínez P; Climent B; Benedito S; García-Sacristán A; Hernández M; Prieto D
    J Sex Med; 2013 Sep; 10(9):2141-53. PubMed ID: 23875673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin and endothelin antagonists: pharmacology and clinical implications.
    Lüscher TF; Wenzel RR
    Agents Actions Suppl; 1995; 45():237-53. PubMed ID: 7717186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.
    Iglarz M; Steiner P; Wanner D; Rey M; Hess P; Clozel M
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):332-7. PubMed ID: 25992919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.
    Spieker LE; Noll G; Lüscher TF
    Am J Cardiovasc Drugs; 2001; 1(4):293-303. PubMed ID: 14728028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin receptor antagonists and their developing role in cardiovascular therapeutics.
    Dupuis J
    Can J Cardiol; 2000 Jul; 16(7):903-10. PubMed ID: 10934309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
    Rafnsson A; Shemyakin A; Pernow J
    Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin System in Hypertension and Chronic Kidney Disease.
    Schiffrin EL; Pollock DM
    Hypertension; 2024 Apr; 81(4):691-701. PubMed ID: 38059359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endothelin-1 and cardiovascular diseases].
    Cracowski JL; Stanke F; Bessard G
    Rev Med Interne; 1999 Jul; 20(7):589-96. PubMed ID: 10434349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin in atherosclerosis: importance of risk factors and therapeutic implications.
    d'Uscio LV; Barton M; Shaw S; Lüscher TF
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S55-59. PubMed ID: 10976783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin ETA receptor antagonism in cardiovascular disease.
    Nasser SA; El-Mas MM
    Eur J Pharmacol; 2014 Aug; 737():210-3. PubMed ID: 24952955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1: Biosynthesis, Signaling and Vasoreactivity.
    Houde M; Desbiens L; D'Orléans-Juste P
    Adv Pharmacol; 2016; 77():143-75. PubMed ID: 27451097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible therapeutic role of endothelin antagonists in cardiovascular disease.
    Ram CV
    Am J Ther; 2003; 10(6):396-400. PubMed ID: 14624276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 and Endothelin-3 Regulate Endothelin Receptor Expression in Rat Coronary Arteries.
    Skovsted GF; Kilic S; Edvinsson L
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):297-305. PubMed ID: 25891848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New expansion of endothelin research: perspectives for clinical application of endothelin-receptor antagonists].
    Goto K; Miyauchi T
    Nihon Yakurigaku Zasshi; 2003 Feb; 121(2):91-101. PubMed ID: 12616854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin ET
    Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
    J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction.
    LaDouceur DM; Flynn MA; Keiser JA; Reynolds E; Haleen SJ
    Biochem Biophys Res Commun; 1993 Oct; 196(1):209-15. PubMed ID: 8216294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.